December 19, 2016Impax Laboratories Inc • March 1st, 2017 • Pharmaceutical preparations • California
Company FiledMarch 1st, 2017 Industry Jurisdiction
General Release and WaiverGeneral Release and Waiver • March 1st, 2017 • Impax Laboratories Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 1st, 2017 Company Industry JurisdictionThis General Release and Waiver (this “Release”) is entered into on December 19, 2016 by G. Frederick Wilkinson (the “Executive”), on the one hand, and Impax Laboratories, Inc. and its subsidiaries and affiliates (collectively, the “Company”), on the other hand (the Executive and the Company are referred to collectively as the “Parties”). Defined terms used but not defined herein shall have the same meaning as set forth in the Employment Agreement between the Executive and the Company dated April 21, 2014 (“Employment Agreement”).